Tirzepatide targets two (GLP-1 and GIP)
In the acute phase, symptoms include euphoria, anxiety, paranoia, and psychomotor agitation, which are primarily caused by the short-term overactivation of neurotransmitter systems (Cruickshank and Dyer, 2009)
Note: To support and expand your research on sleep peptides and neurological function, explore our dedicated selection of Nasal Sprays
Similarly, a 2017 double-blind, placebo-controlled trial found that oral administration of ALA (1,200 mg/day) for eight weeks induced mild weight loss accompanied by a reduction in waist circumference
These peptides are a possible treatment for leaky gut syndrome because they cooperate to lower inflammation, encourage tissue regeneration, and enhance general gut health